Clinical Trials Logo

Clinical Trial Summary

The participants are being asked to take part in this clinical trial, a type of research study, because the participants are scheduled to receive or have recently received a hematopoietic cell transplant (HCT) or a solid organ transplant (SOT). Primary Objective To determine if pre-transplant screening for respiratory viral load predicts RVI within 1- year post-transplant among survivors. Secondary Objectives: - To develop and validate a classifier based on pre-transplant immunological profile predictive of developing an acute respiratory viral infection (aRVI), with RSV/PIV3/HMPV/SARS-CoV-2 through one-year post-transplant among survivors. - To develop and validate a classifier based on Day +100 post-transplant immunological profiles predictive of developing an acute respiratory viral infection (aRVI),with RSV/PIV3/HMPV/SARS-CoV-2 through one-year post-transplant among survivors .


Clinical Trial Description

The investigators will collect a nasal swab and blood sample from the participant when the participant is enrolled on the study and if the participant develops a RVI in the first year after transplant. The investigators will collect a blood sample 100 days after the participant's transplant. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05550298
Study type Observational
Source St. Jude Children's Research Hospital
Contact Gabriela Maron, MD
Phone 866-278-5833
Email referralinfo@stjude.org
Status Recruiting
Phase
Start date December 13, 2022
Completion date August 2029

See also
  Status Clinical Trial Phase
Terminated NCT04898023 - Zinc and Green Tea Extract for Community Respiratory Viral Infections Phase 2
Withdrawn NCT04842331 - PREvent Viral Exposure and Transmission Study: a COVID-19 (SARS-CoV-2) PEP Study (PREVENT) Phase 2/Phase 3
Completed NCT02260596 - Respiratory Viral Infections in Pediatric Transplantation N/A
Not yet recruiting NCT06099873 - A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Trial of ZX-7101A Tablets to Evaluate the Efficacy and Safety in the Treatment of Uncomplicated Influenza in Adolescents Phase 3
Completed NCT04898140 - The Evaluation of Cellular and Humoral Immunity to COVID-19 in Moscow Residents
Completed NCT04611061 - Kagocel® for the Prevention of ARVI and Influenza in Adults Health Care Workers
Not yet recruiting NCT05618483 - Xylitol Based Nasal Spray for COVID-19 Treatment N/A
Recruiting NCT06149494 - RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection Phase 2
Terminated NCT04141917 - Test-and-treat for Influenza in Homeless Shelters Phase 4
Recruiting NCT06017310 - Respiferon Project
Enrolling by invitation NCT06188988 - Viral Infections and Airway Microbiome in Young Children With Cystic Fibrosis
Completed NCT04141930 - Pilot of Cohort of Households for Influenza Monitoring and Evaluation in Seattle Phase 4
Completed NCT05846360 - The Technical and Operational Performance of the QuidelOrtho Savanna RVP4 Analyzer
Completed NCT04532411 - COVID-19 Testing Sample Acquisition Throughput and Efficiency
Active, not recruiting NCT04258059 - Wells and Enteric Disease Transmission Trial (WET - Trial) N/A
Active, not recruiting NCT04482673 - Vitamin D Supplementation in the Prevention and Mitigation of COVID-19 Infection Phase 4
Not yet recruiting NCT05946538 - Clinical Evaluation of SARS-COV-2 (COVID-19), Influenza and RSV 8-Well MT-PCR Panel for In Vitro Diagnostics N/A
Recruiting NCT05092607 - Evaluation of the Detection Performance of the N Antigenemia of SARS-CoV-2 in the General Population for the Diagnosis and Screening of COVID-19 N/A
Recruiting NCT05913700 - Effect of Respiratory Virus Infection on EmeRgencY Admission Study (EVERY Study)
Recruiting NCT04826991 - Wells and Enteric Disease Transmission N/A